VISTAAR @vistaarai - Tumblr Blog

In the years, ahead Asia might see a surge in the growth of medical device industry. Globally there has been a rise in the export of product and technologies from Asia. Diversity within this continent poses a great challenge towards creating a harmonized regulation for medical devices.

Regulatory reforms are necessary as they offer room for innovation and increases efficiency. Simultaneous cost reductions have a positive impact on the national economy and keeps the competition alive allowing the companies to adapt with the changes. Once undertaken, a regulatory reform can aid in bringing about several other reform policies apt for the nation.

#Medical Device Regulations #Asian Medical Device Regulations #Harmonizing Medical Device Regulations #medical devices #VISTAAR

•18+ Adults Only

Watch Anya Live on Cam

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.

✓ Live Streaming✓ Interactive Chat✓ Private Shows✓ HD Quality✓ Free Actions

Free to watch • No registration required • HD streaming

VISTAAR

The European Commission, European Medicines Agency and Heads of Medicines Agencies reminded clinical trial sponsors that they must comply with EU clinical trial rules following the Brexit transition period that expires on 31 December 2020.

#Drug regulatory updates #drug regulations #regulatory requirements #Vistaar

VISTAAR

745A(b) of the Federal Food, Drug,and Cosmetic Act (FD&C Act), amended by section 207of the FDA Reauthorization Act of 2017(FDARA) (Pub. L. 115-52), requires thatpre-submissions and submissions for devices under section 510(k), 513(f)(2)(A), 515(c), 515(d), 515(f), 520(g), 520(m), or 564 of the FD&C Act or section 351 of the Public Health Service Act, and any supplementsto such pre-submissions or submissions, including appeals of those submissions, be submitted in electronic format specified by the Food and Drug Administration (FDA or the Agency)beginning on such date as specified by FDA in final guidance.

#medical device regulations #medical devices #medical device news #Vistaar

Latest Medical Device Regulatory updates - July 2020

Communication concerning the return of deposits and the evaluation of advertising visas for pharmaceutical specialties, medical devices and in vitro diagnostic medical devices - Information Point

Regarding DM and DMDIV advertising visas

For DMs and DMDIVs whose advertising must be subject to a prior authorization request, the filing of these advertising requests can be made at any time during the year. The ANSM has a period of 2 months, from the date of receipt of the complete file, to authorize publicity or notify the applicant of a reasoned refusal. Beyond this period and without response from the ANSM, the request is deemed accepted.

For requests whose evaluation was to end during the legally protected period (from March 12 to June 23, 2020 inclusive), the evaluation period is suspended and resumes its course, for the remaining period, from 24 June 2020. The absence of an Agency decision at the end of this period will constitute implied authorization.

For requests whose evaluation was to start and expire during the legally protected period, the starting point of the evaluation period is postponed, for the initial period of 2 months, to June 24, 2020. These requests will be deemed to have been accepted in no decision as of August 24, 2020.

Regarding expiring advertising visas

Provided that no decision modifying them or terminating has been pronounced, advertising visas the validity period to expire between 12 March and 1st December 2020 are extended by right until 31 December 2020.

#medical devices #medical device regulations #medical device news #Medical Device updates #VISTAAR

Latest Drug Regulatory updates - July 2020

European Commission to Propose Relaxation of GMO Regulations for COVID-19 Vaccines

European Commission (EC) proposed relaxation to regulations of genetically modified organisms (GMOs)to ensure that clinical trials with medicinal products for human use that contain or consist of GMO's and are intended to treat or prevent COVID-19.

#drug regulations #Drug regulatory updates #Drug Regulatory news #Drug Regulatory intelligence #VISTAAR

•18+ Adults Only

Watch Anya Live on Cam

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.

✓ Live Streaming✓ Interactive Chat✓ Private Shows✓ HD Quality✓ Free Actions

Free to watch • No registration required • HD streaming

medical Devices from Premarket Clinical consultations

A new interpretation of Medical Device Regulation (MDR) recently updated Article 54 (2)b has been forwarded by the Medical Device Coordination Group (MDCG). According to MDCG, there are certain criteria under which medical devices can be exempted from premarket clinical evaluation consultations to be held before an expert panel.

#Premarket Clinical consultation #clinical evaluation consultation #Medical Device Directive #Medical Device Regulations

Blog

Eight best Regulatory practices to gain easy approvals from authorities. Build a unique and effective regulatory strategy, ensure compliance and remain ahead of the race. Read now at https://www.vistaar.ai/blogs/Building-Regulatory-Capacity-Best-Practices-for-the-Future

#Regulatory Intelligence software #Clinical Intelligence Software #Regulatory guidelines #Regulatory compliance #Regulatory Strategy #Regulatory best practices

Global Clinical and regulatory Intelligence software

VISTAAR offers an exclusive Regulatory Summarize feature that will help you to reduce spending time on Regulatory documents and the pre-compiled data can be viewed in a country specific, business specific and even functional group specific manner. You can get 100+ countries Regulatory information for registration requirements. Know more at https://bit.ly/2n5Kfgr

#Regulatory Reports #Regulatory Summary Reports #VISTAAR #Regulatory Intelligence #Clinical Intelligence

Princeton, NJ (PRWEB) September 17, 2019 -- VISTAAR released ADVISORY Playbooks to help small and mid-level companies who need advisory either as a primary

VISTAAR released ADVISORY Playbooks to help small and mid-level companies who need advisory either as a primary strategy or as re-assurance / 2nd opinion to their internal strategies they formed for developing or launching new products or expanding to new countries.

Continue Reading at https://bit.ly/2lj7bbk

#Clinical Intelligence #Regulatory Intelligence #Drug Regulations #Pharma Regulations #Medical Device Regulations #VISTAAR

With the recent announcement from FDA’s Center for Devices and Radiological Health (CDRH) about their finalization of guidelines towards accepting a higher premarket uncertainty with regards to the benefit-risks of medical devices, things might change for the better.

Continue Reading at https://bit.ly/2kthqcF

#Medical Device Regulations #Regulatory Guidance #Regulatory Intelligence #Regulatory Technology #Medical Technology #Clinical Intelligence

•18+ Adults Only

Watch Anya Live on Cam

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.

✓ Live Streaming✓ Interactive Chat✓ Private Shows✓ HD Quality✓ Free Actions

Free to watch • No registration required • HD streaming

Regulatory necessities for post-approval modifications depend on the country regulations. It is a tough and expensive process for applicants to handle changes of the approved regulatory folder of documents over the lifecycle of the product when it gets registration in multiple countries. Continue Reading at https://bit.ly/2MK4rQg

#Regulatory Intelligence #Clinical Intelligence #Regulatory Intelligence software #Regulatory updates #Medical Device regulations #Pharma Regulations #Drug Regulations #Regulatory CMC

Cybersecurity Issues in Medical Technology

Newer inventions and discoveries are filling up the world fast. With every new invention, bulk data gets accumulated which needs storing and protection. Protection from what? These are confidential data and the hackers are just on the lookout for such data. In order to protect these, cybersecurity is the only way out.

Download FREE VISTAAR whitepaper at https://bit.ly/31S3x7Q

#Medical Technology #Cybersecurity issues #Medical Devices #Med Tech #Regulatory Intelligence

The Medical device industry is well regulated by the FDA in the US, and many regional bodies internationally, including the EU MDD (Medical Device Directive) and the ASEAN MDD.

The Medical device industry is well regulated by the FDA in the US, and many regional bodies internationally, including the EU MDD (Medical Device Directive) and the ASEAN MDD. These agencies detail requirements for the life cycle of medical devices from design, trials, documentation, labeling, packaging, delivery, and adverse event reporting – all in the name of make the most of device safety and providing the utmost opportunity for positive patient outcomes.

Read more at https://bit.ly/2ZgC1iV

#Medical Device Labeling #Medical device industry #Medical Device Directive #labeling #Regulatory Intelligence software #Medical Device Labeling Requirements

Regulatory Intelligence (RI) unbolts all your Regulatory Challenges

Drug development has become highly complex than ever before since the globalization of the life sciences industry. Regulatory Intelligence (RI), which emerged about 15 years ago, is comparatively a new global regulatory affairs (RA) division. RI provides up-to-date information of current regulations affecting the development, approval, and maintenance, as well as any changes to the regulations and/or regulatory landscape that impact the products.

Continue Reading @ https://bit.ly/2YybqNL

#Regulatory Intelligence #Regulatory Intelligence tool #Regulatory Challenges #Regulatory Requirements #Medical Device Regulations #drug Regulations

Medical Device Regulations

European Medicines Agency has released a draft guideline on the quality requirements for medical devices in human medicines that include a medical device, known as drug-device combinations, for a 3-month public consultation. Continue Reading at http://bit.ly/2G09O8X

#European Medicines Agency #EMA #Medical Device regulations #Drug regulations #Regulatory intelligence software #Clinical Intelligence Software

•18+ Adults Only

Watch Anya Live on Cam

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.

✓ Live Streaming✓ Interactive Chat✓ Private Shows✓ HD Quality✓ Free Actions

Free to watch • No registration required • HD streaming

Leveraging artificial intelligence, technology provides comprehensive coverage and actionable insights on global regulatory information for drugs, biologics, and devices of about 90 countries.

VISTAAR is a Global Regulatory and Clinical Intelligence Platform which focuses exclusively on providing Regulatory Intelligence(RI) and Clinical Intelligence (Clin Intel) solution for drugs, devices, combination products, biologics, generics, active pharmaceutical ingredients and animal health drugs thereby supporting pharmaceutical and medical device companies starting from overview of any country’s regulations or requirement to assess the regulatory needs for product registration and answering to any focused regulatory query.

#Regulatory Intelligence Software #Clinical Intelligence Software #Regulatory Intelligence #Regulatory affairs intelligence #Regulatory intelligence biotech #Regulatory medical devices

Global Regulatory & Clinical Intelligence Software

VISTAAR is a Global Regulatory and Clinical Intelligence Platform which focuses exclusively on providing Regulatory Intelligence (RI) and Clinical Intelligence (Clin Intel) solution for drugs, devices, combination products, biologics, generics, active pharmaceutical ingredients and animal health drugs.

#Global Regulatory & Clinical Intelligence #Regulatory Intelligence #Regulatory Intelligence Tool #Regulatory Intelligence software #Regulatory Intelligence Platform #regulatory intelligence in pharmaceutical industry #regulatory intelligence in Medical Devices #regulatory intelligence in Drugs

Trending Blogs

Last Seen Blogs

VISTAAR